Oral steroids do not increase risk of Covid-19 in patients o
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
The role of corticosteroids in treating severe infections has been enduring controversy. During the Covid-19 pandemic, rigorous data on the efficacy of corticosteroids have been limited. In a recent study, researchers found that in patients with chronic rhinosinusitis (CRS), oral corticosteroids (OCS) does not increase the risk of Covid 19 infection.

This study thus sought to explore the association between the use of OCSs and the development of COVID-19 in patients with CRS. The study was published in the journal Otolaryngology-Head & Neck Surgery.

Researchers found no statistically significant difference in the rates of patients with a positive diagnosis of COVID-19 who underwent an OCS treatment regimen compared to those who did not, both within 28 days and 14 days prior to the COVID-19 test.

Overall, given OCSs are often a major component of the medical management of CRS, this study proves helpful in counseling patients on risks of steroid use in CRS treatment during the COVID-19 pandemic.

Source: https://doi.org/10.1177/01945998211006931
Like
Comment
Share